PESCARMONA, Gianpiero

PESCARMONA, Gianpiero  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 142 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autore(i) File
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. 1992 CALVINO R ;FRUTTERO R ;GHIGO D ;BOSIA A ;PESCARMONA GP ;GASCO A
[Changes in erythrocyte deformability following changes in oxido-reductive metabolism in diabetes mellitus] 1983 GHIGO D ;BOSIA A ;PAGANI A ;PESCARMONA GP ;PAGANO G ;LENTI G
[The molecular basis for increased rigidity of the erythrocyte membrane] 1983 PESCARMONA GP ;GHIGO D ;BOSIA A
A culture medium and pharmaceutical composition for regenerating cartilage tissue, a method, uses and products related thereto 2007 GENNERO L; PONZETTO A; DE VIVO E; CONTU L; MORRA E; CESANO C; CAVALLO G; CICERO G; PESCARMONA GP; DENYSENKO T; ROOS MA; SARA M
A Dedicated Image Analysis Software Tool for the Evaluation of the Resorption Activity of Cultured Osteoclasts 2008 BRIANZA S.Z.M; D'AMELIO P.; CERRATO M; BIGNARDI C; GRIMALDI A; PESCARMONA G.P; ISAIA G
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells 2011 Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C
A novel composition for in vitro and in vivo regeneration of skin and connective tissues. 2011 Gennero L; De Siena R; Denysenko T; Roos MA; Calisti GF; Martano M; Fiobellot S; Panzone M; Reguzzi S; Gabetti L; Vercelli A; Cavallo G; Ricci E; Pescarmona GP
A physical-based model for the simulation of neoplastic growth and metastasis. 2000 MAGNANO M.; BONGIOANNINI G.; LERDA W.; GALVAGNO MB.; TONDOLO E.; CANALE G.; CAPOGROSSO B.; DELSANTO PP.; SCALERANDI M.; G. PESCARMONA
A simplified method for the pentose phosphate pathway assay in red cells. 1982 PESCARMONA GP ;BOSIA A ;ARESE P ;SARTORI ML ;GHIGO D
Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. 1988 F. BUSSOLINO; G. PESCARMONA; G. CAMUSSI; F. GREMO
Activation of endothelial guanylate cyclase inhibits cellular reactivity. 1995 HELLER R ;BUSSOLINO F ;GHIGO D ;PESCARMONA GP ;CALVINO R ;GASCO A ;TILL U ;BOSIA A
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells 2008 Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. 2001 MARTINA V; BRUNO GA; ZUMPANO E; ORIGLIA C; QUARANTA L; GP. PESCARMONA
Alendronate reduces osteoclast precursors in osteoporosis 2010 P D’Amelio; A Grimaldi; MA Cristofaro; M Ravazzoli; PA Molinatti; GP Pescarmona; G Isaia
Analysis and Prototyping of Biological Systems 2005 DI LEVA A; BERCHI R; PESCARMONA G.; SONNESSA M
Analysis and Prototyping of Biological Systems: the Abstract Biological Process Model 2005 DI LEVA A; BERCHI R; PESCARMONA G.; SONNESSA M
Analysis of a 'phase transition' from tumor growth to latency. 2000 DELSANTO PP; ROMANO A; SCALERANDI M; G. PESCARMONA
Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer 2010 Silvagno F; Poma CB; Realmuto C; Ravarino N; Ramella A; Santoro N; D'Amelio P; Fuso L; Pescarmona G; Zola P
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression 2009 Riganti C; Doublier S; Viarisio D; Miraglia E; Pescarmona G; Ghigo D; Bosia A
Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition 2007 RIGANTI C; ORECCHIA S; SILVAGNO F; PESCARMONA GP; BETTA PG; GAZZANO E; ALDIERI E; GHIGO D; BOSIA A